Oracle-TikTok Pop; Kenvue Lower; Mag 7 and H-1B Visas

On this episode of Stock Movers:
- Oracle (ORCL) is rising his morning on news would recreate and provide security for a new US version of TikTok's algorithm under a deal to sell the app to a consortium of American investors. Oracle will operate in partnership with the US government on everything from algorithm retraining to application development and source code review to ensure content is free from improper manipulation or surveillance.
- Kenvue (KVUE) is lower on a report from the Washington Post that Trump administration officials plan to link the active ingredient in Tylenol to autism and warn pregnant women against using the medication unless they have a fever. Kenvue, the maker of Tylenol, said "independent, sound science" shows taking acetaminophen does not cause autism and expressed concern over the health risk this poses for expecting mothers.
- Pfizer (PFE) is moving as it agreed to buy the obesity startup Metsera Inc. for an enterprise value of about $4.9 billion to bolster its pipeline after a key weight-loss pill foundered. The US drugmaker will pay Metsera $47.50 in cash per share, and further payments of up to $22.50 per share if three specific and regulatory milestones are met, it said in a statement Monday. The deal represents a 43% premium to Metsera’s closing share price on Friday.
- Amazon (AMZN), Microsoft (MSFT), and Meta (META) are among Mag 7 names mostly unchanged amid news of H-1B visas. President Trump signed a proclamation to overhaul the H-1B visa program, requiring a $100,000 fee for applications to curb overuse. The proclamation restricts entry under the H-1B program unless accompanied by the payment, and asserts that abuse of the H-1B pathway has displaced US workers.

See omnystudio.com/listener for privacy information.